Anhui Huaheng Biotechnology Past Earnings Performance
Past criteria checks 3/6
Anhui Huaheng Biotechnology has been growing earnings at an average annual rate of 38.7%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 39.5% per year. Anhui Huaheng Biotechnology's return on equity is 23.7%, and it has net margins of 22.3%.
Key information
38.7%
Earnings growth rate
31.8%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | 39.5% |
Return on equity | 23.7% |
Net Margin | 22.3% |
Next Earnings Update | 28 Aug 2024 |
Recent past performance updates
Recent updates
Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?
Jun 21Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper
Jun 05We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease
May 12Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%
Apr 23Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't
Mar 18Revenue & Expenses Breakdown
How Anhui Huaheng Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 2,039 | 454 | 181 | 113 |
31 Dec 23 | 1,938 | 449 | 172 | 109 |
30 Sep 23 | 1,799 | 423 | 166 | 97 |
30 Jun 23 | 1,640 | 382 | 158 | 100 |
31 Mar 23 | 1,548 | 346 | 151 | 90 |
31 Dec 22 | 1,419 | 320 | 145 | 79 |
30 Sep 22 | 1,317 | 283 | 131 | 78 |
30 Jun 22 | 1,203 | 235 | 112 | 67 |
31 Mar 22 | 1,059 | 192 | 98 | 59 |
31 Dec 21 | 954 | 168 | 80 | 53 |
30 Sep 21 | 748 | 138 | 58 | 39 |
30 Jun 21 | 608 | 118 | 54 | 31 |
31 Mar 21 | 523 | 120 | 42 | 28 |
31 Dec 20 | 487 | 121 | 43 | 30 |
31 Dec 19 | 491 | 126 | 50 | 30 |
31 Dec 18 | 421 | 76 | 59 | 22 |
31 Dec 17 | 383 | 65 | 33 | 20 |
30 Jun 17 | 367 | 72 | 52 | 0 |
31 Mar 17 | 339 | 67 | 49 | 0 |
31 Dec 16 | 311 | 62 | 46 | 0 |
30 Sep 16 | 282 | 51 | 42 | 0 |
30 Jun 16 | 253 | 40 | 39 | 0 |
31 Mar 16 | 253 | 41 | 37 | 0 |
31 Dec 15 | 253 | 43 | 34 | 0 |
30 Sep 15 | 249 | 34 | 44 | 0 |
30 Jun 15 | 244 | 41 | 35 | 0 |
31 Mar 15 | 235 | 40 | 33 | 0 |
31 Dec 14 | 225 | 23 | 50 | 0 |
30 Sep 14 | 216 | 27 | 38 | 0 |
30 Jun 14 | 207 | 30 | 25 | 0 |
31 Mar 14 | 190 | 22 | 24 | 0 |
31 Dec 13 | 173 | 13 | 22 | 0 |
Quality Earnings: 688639 has a high level of non-cash earnings.
Growing Profit Margin: 688639's current net profit margins (22.3%) are lower than last year (22.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688639's earnings have grown significantly by 38.7% per year over the past 5 years.
Accelerating Growth: 688639's earnings growth over the past year (31.3%) is below its 5-year average (38.7% per year).
Earnings vs Industry: 688639 earnings growth over the past year (31.3%) exceeded the Chemicals industry -16.4%.
Return on Equity
High ROE: 688639's Return on Equity (23.7%) is considered high.